ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.44	17.57	22.41	48.82	363.67	434.22
Short-Term Investments	37.18	110.19	160.33	217.39	-	-
Cash & Short-Term Investments	60.63	127.76	182.74	266.21	363.67	434.22
Cash Growth	-59.20%	-30.09%	-31.36%	-26.80%	-16.25%	4715.56%
Other Receivables	0.4	0.89	1	-	-	-
Receivables	0.4	0.89	1	-	-	-
Prepaid Expenses	5.49	5.68	4.49	4.76	3.35	1.77
Other Current Assets	-	0.03	0.44	-	-	-
Total Current Assets	66.52	134.35	188.66	270.97	367.02	435.99
Property, Plant & Equipment	4.41	9.63	10.84	9.81	3.47	0.05
Long-Term Investments	5.84	3.52	35.41	16.7	-	-
Other Long-Term Assets	5.96	0.27	7.64	9.01	9.69	0.01
Total Assets	82.72	147.78	242.55	306.49	380.18	436.05
Accounts Payable	6.58	4.5	8.59	8.07	3.76	0
Accrued Expenses	13.5	9.26	15.44	10.79	9.6	3.68
Current Portion of Long-Term Debt	4.35	0.44	-	-	-	-
Current Portion of Leases	1.93	1.91	-	-	0.74	-
Current Income Taxes Payable	-	-	-	-	-	0.18
Other Current Liabilities	1.36	2.39	11.97	9.46	1.19	2.35
Total Current Liabilities	27.72	18.5	36	28.33	15.3	6.2
Long-Term Debt	5.76	9.47	9.64	9.39	-	-
Long-Term Leases	3.57	5.16	-	-	-	-
Other Long-Term Liabilities	0.87	1.03	7.2	5.31	1.84	0.01
Total Liabilities	37.92	34.16	52.84	43.03	17.13	6.21
Common Stock	0.05	0.05	0.05	0.04	0.04	0.04
Additional Paid-In Capital	744.67	734.41	675.68	589.74	564.99	548.33
Retained Earnings	-699.97	-621.12	-486.27	-325.47	-201.99	-118.52
Comprehensive Income & Other	0.04	0.28	0.26	-0.85	-	-
Total Common Equity	44.8	113.62	189.71	263.46	363.05	429.85
Shareholders' Equity	44.8	113.62	189.71	263.46	363.05	429.85
Total Liabilities & Equity	82.72	147.78	242.55	306.49	380.18	436.05
Total Debt	15.61	16.98	9.64	9.39	0.74	-
Net Cash (Debt)	45.02	110.78	173.1	256.82	362.93	434.22
Net Cash Growth	-65.69%	-36.00%	-32.60%	-29.24%	-16.42%	11975.06%
Net Cash Per Share	0.84	2.12	4.03	6.31	9.00	23.49
Filing Date Shares Outstanding	54.22	53.38	50.15	40.86	40.63	40.13
Total Common Shares Outstanding	53.58	53.05	49.95	40.86	40.59	39.84
Working Capital	38.79	115.85	152.66	242.64	351.72	429.79
Book Value Per Share	0.84	2.14	3.80	6.45	8.94	10.79
Tangible Book Value	44.8	113.62	189.71	263.46	363.05	429.85
Tangible Book Value Per Share	0.84	2.14	3.80	6.45	8.94	10.79
Machinery	2.47	2.47	2.31	1.93	0.73	0.07
Leasehold Improvements	0.71	2.51	2.51	2.36	0.23	0.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q